| 摘要 |
Disclosed is a method of lowering levels of fat accumulation, low density lipoprotein (LDL), or cholesterol; or treating cardiovascular disease by lowering LDL/cholesterol, comprising administering a therapeutically effective amount of an isolated antibody reactive with TLR3 (Toll-Like Receptor 3) |
